Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS44015196HTLV-1ENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS44002399HTLV-1ENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS44010875HTLV-1ENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS44034377HTLV-1ENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS44049463HTLV-1ENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TVIS44035588HTLV-1ENSG00000151067.23protein_codingCACNA1CNoNo775A0A0A0MR67
A0A0A0MSA1
F5H522
Q13936
Q5V9X9
TCGA Plot Options
Drug Information
GeneCACNA1C
DrugBank IDDB12278
Drug NamePropiverine
Target IDBE0000430
UniProt IDQ13936
Regulation Typeantagonist
PubMed IDs16406943
CitationsMaruyama S, Oki T, Otsuka A, Shinbo H, Ozono S, Kageyama S, Mikami Y, Araki I, Takeda M, Masuyama K, Yamada S: Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder. J Urol. 2006 Jan;175(1):365-9.
GroupsApproved; Investigational
Direct ClassificationDiphenylmethanes
SMILESCCCOC(C(=O)OC1CCN(C)CC1)(C1=CC=CC=C1)C1=CC=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL1078261